Mitosense, Inc, based in Great Falls, VA, is a pioneering biotech company that specializes in harnessing the power of mitochondria to combat neurodegenerative diseases. With exclusive licensing to their groundbreaking Mitochondria Organelle Transplantation (MOT) technology, they have demonstrated proof of concept for this cellular biotherapy, offering hope to millions of individuals suffering from conditions such as ALS, Parkinson's, and Alzheimer's.
Through their dedicated research efforts over the past decade, Mitosense, Inc has focused on mitochondrial dysfunction in cancer, leading to the evaluation of its potential in neurodegenerative diseases. Their innovative MOT technology not only holds great promise for those currently afflicted by these conditions but also shows indications of broader applications that could benefit millions of Americans facing various neurodegenerative issues and diseases.
Generated from the website